Скачать или смотреть Drug discovery requires AI AND structured data

Siemens Digital Industries Software CEO Tony Hemmelgarn shares candid insights from Realize LIVE 2025 Detroit about the Dotmatics acquisition and why simply "throwing AI" at drug discovery won't work. Recounting a conversation with Dotmatics CEO Thomas Swalla, he addresses several real challenges facing pharmaceutical innovation.

Excerpted from Tony Hemmelgarn's remarks to media and analysts at Realize LIVE 2025.

Key Insights:
🧬 Why AI alone won't revolutionize drug discovery
📊 The critical missing piece: structured data in pharma
🔗 How Dotmatics' 19 acquisitions + Luma platform create the foundation
💊 Siemens' unique position bridging drug discovery to manufacturing
🏭 The digital twin concept applied to life sciences


[00:00:00] - Opening: Beyond data lakes in life sciences
[00:00:30] - Thomas Swalla on Siemens: "You may be largest software company people haven't heard of"
[00:01:00] - The AI reality check for drug discovery
[00:01:30] - Dotmatics' approach: 19 companies, APIs, and Luma platform
[00:02:00] - Introducing digital twins to pharma
[00:02:30] - Siemens' existing pharma footprint: MES, med devices, process automation

Thomas Swalla's key quote: "This whole idea of you can just throw AI at a problem is nonsense. It's not going to solve drug discovery."

Learn more about the acquisition: https://sie.ag/4yatBa

#SiemensDigitalIndustries #Dotmatics #DrugDiscovery #RealizeLIVE2025